Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Epidemiology of movement disorders.

Tanner CM, Goldman SM.

Curr Opin Neurol. 1994 Aug;7(4):340-5. Review. No abstract available.

PMID:
7952243
2.

Movement disorders in the psychiatric patient.

Moros DA, Yahr MD.

Hosp Community Psychiatry. 1984 Apr;35(4):377-83. Review.

PMID:
6232196
3.

Involuntary movement disorders.

Still CN.

Neurol Clin. 1984 Feb;2(1):71-89. Review.

PMID:
6239089
4.

New opinions of pathomechanisms of involuntary movements.

Iłzecka J.

Ann Univ Mariae Curie Sklodowska Med. 1994;49:99-104. Review. No abstract available.

PMID:
8771836
5.

Post-traumatic movement disorders: central and peripheral mechanisms.

Jankovic J.

Neurology. 1994 Nov;44(11):2006-14. Review. No abstract available.

PMID:
7969951
6.

[Tardive dyskinesia].

Sabbatini F, Gentile S, De Mattei M, Pinessi L, Rainero I.

Minerva Med. 1985 Apr 14;76(16):797-802. Review. Italian.

PMID:
2860619
7.

Movement disorders.

Minagar A, Kelley RE.

Prim Care. 2004 Mar;31(1):111-27. Review. No abstract available.

PMID:
15110162
8.

The pathogensis and medical treatment of extrapyramidal disease.

Calne DB, Eisler T.

Med Clin North Am. 1979 Jul;63(4):715-27. Review. No abstract available.

PMID:
157413
9.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review.

PMID:
22749259
10.

Current concepts in the management of movement disorders.

Olanow CW.

Clin Neurosurg. 1981;28:137-70. Review. No abstract available.

PMID:
6119175
11.

[Pisa syndrome].

Harada K, Saito T.

Ryoikibetsu Shokogun Shirizu. 2003;(38):199-202. Review. Japanese. No abstract available.

PMID:
12876965
12.

[Dystonia: their epidemiology, aetiology, diagnosis and treatment].

Rodríguez-Constela I, Rodríguez-Regal A, Cebrián-Pérez EM.

Rev Neurol. 2009 Jan 23;48 Suppl 1:S61-9. Review. Spanish.

13.

Epidemiology of tardive dyskinesia.

Kane JM, Woerner M, Weinhold P, Kinon B, Lieberman J, Wegner J.

Clin Neuropharmacol. 1983 Jun;6(2):109-15. Review. No abstract available.

PMID:
6342767
14.

Movement disorders.

Cardoso F, Jankovic J.

Neurol Clin. 1993 Aug;11(3):625-38. Review.

PMID:
8377747
15.

Peripherally induced movement disorders.

Jankovic J.

Neurol Clin. 2009 Aug;27(3):821-32, vii. doi: 10.1016/j.ncl.2009.04.005. Review.

PMID:
19555833
16.

Oxygen radicals and neuropsychiatric illness. Some speculations.

Lohr JB.

Arch Gen Psychiatry. 1991 Dec;48(12):1097-106. Review.

PMID:
1845228
17.

Dysphagia in movement disorders.

Logemann JA.

Adv Neurol. 1988;49:307-16. Review. No abstract available.

PMID:
2964174
18.

Epidemiology of Parkinson's disease and movement disorders in India: problems and possibilities.

Muthane UB, Ragothaman M, Gururaj G.

J Assoc Physicians India. 2007 Oct;55:719-24. Review.

PMID:
18173026
19.

[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].

Destee A.

LARC Med. 1984 Feb;4(2):107-11. Review. French. No abstract available.

PMID:
6232436
20.

Cannabis in movement disorders.

Müller-Vahl KR, Kolbe H, Schneider U, Emrich HM.

Forsch Komplementarmed. 1999 Oct;6 Suppl 3:23-7. Review.

PMID:
10627163

Supplemental Content

Support Center